Wanbangde Pharmaceutical Holding Group Co., Ltd.

Announcement on Abnormal Fluctuations in Stock Trading

Announcement on Abnormal Fluctuations in Stock Trading

Announcement on the Subsidiary's Receipt of Notification for Granting Invention Patent Rights

Announcement on the Shareholding Information of the Top Ten Shareholders and Top Ten Unrestricted Shareholders Before the Share Buyback

Share Buyback Report

Announcement on the Resolutions of the 23rd Meeting of the Ninth Board of Directors

Plan for the Repurchase of Company Shares

Announcement on Abnormal Fluctuations in Stock Trading

Announcement on Participating in the 2026 Online Collective Reception Day for Investors of Listed Companies in Zhejiang Province and the 2025 Annual Performance Briefing

Announcement on Abnormal Fluctuations in Stock Trading

Announcement on the pledge of part of the shares by the controlling shareholder

Risk warning announcement regarding the potential delisting risk warning for the company's stock trading.

Announcement on the Reappointment of the Company's Audit Institution for 2026

Independent Director's Work Report (Zhou Yuejiang)

Independent Director's Work Report (Tu Pengfei)

Independent Director's Work Report (Li Yang)

Internal Control Audit Report

2025 Internal Control Evaluation Report

Announcement on the Provision for Asset Impairment

Announcement on Providing Financial Assistance to Wholly-owned Subsidiaries and Related Transactions

Announcement on the Estimated Guarantee Limit for the Company in 2026

Notice of the 2025 Annual Shareholders' Meeting

Announcement of the 21st Meeting Resolution of the Ninth Board of Directors

Announcement on the Proposal Not to Distribute Profits for the Year 2025

2026 First Quarter Report

Special Explanation on Matters Involved in the Reserved Opinion Issued by the Accounting Firm

Audit Committee's Special Explanation on Matters Involved in the 2025 Non-standard Audit Opinion

Board of Directors' Special Explanation on Matters Involved in the Company's 2025 Non-standard Audit Opinion

Special Verification Opinion on Revenue Deduction Matters

2025 Evaluation Report on the Performance of the Audit Institution and the Audit Committee's Supervision Responsibilities

2025 Annual Report on the Performance of the Audit Committee of the Board of Directors

Special Explanation on the Fund Occupation Situation of Controlling Shareholders and Other Related Parties

Board of Directors' Special Opinion on the Independence Assessment of Independent Directors

2025 Annual Work Report of the Board of Directors

2025 Annual Audit Report

2025 Annual Report

Summary of the 2025 Annual Report

Announcement on the Company's Stock Trading Being Subject to Other Risk Warnings and Stock Suspension and Resumption

Announcement on Changing the Disclosure Time of the Company's 2025 Annual Report

Announcement on Abnormal Fluctuation of Stock Trading

Announcement on the resignation of the company's deputy general manager and board secretary

Announcement on Abnormal Fluctuations in Stock Trading

Announcement on Abnormal Stock Trading Fluctuations

Announcement on Partial Share Pledge by Controlling Shareholder

2026 First Quarter Performance Forecast

2025 Annual Performance Express Report

Announcement on Partial Share Pledge and Release of Pledge by the Controlling Shareholder